Document Detail


Repetitive ischemia by coronary stenosis induces a novel window of ischemic preconditioning.
MedLine Citation:
PMID:  18936329     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The hypothesis of the present study was that molecular mechanisms differ markedly when mediating ischemic preconditioning induced by repetitive episodes of ischemia versus classic first- or second-window preconditioning.
METHODS AND RESULTS: To test this, chronically instrumented conscious pigs were subjected to either repetitive coronary stenosis (RCS) or a traditional protocol of second-window ischemic preconditioning (SWIPC). Lethal ischemia, induced by 60 minutes of coronary artery occlusion followed by reperfusion, resulted in an infarct size/area at risk of 6+/-3% after RCS and 16+/-3% after SWIPC (both groups P<0.05, less than shams 42+/-4%). Two molecular signatures of SWIPC, the increased expression of the inducible isoform of nitric oxide synthase and the translocation of protein kinase Cepsilon to the plasma membrane, were observed with SWIPC but not with RCS. Confirming this, pretreatment with a nitric oxide synthase inhibitor prevented the protection conferred by SWIPC but not by RCS. Microarray analysis revealed a qualitatively different genomic profile of cardioprotection between ischemic preconditioning induced by RCS and that induced by SWIPC. The number of genes significantly regulated was greater in RCS (5739) than in SWIPC (2394) animals. Of the 5739 genes regulated in RCS, only 31% were also regulated in SWIPC. Broad categories of genes induced by RCS but not SWIPC included those involved in autophagy, endoplasmic reticulum stress, and mitochondrial oxidative metabolism. The upregulation of these pathways was confirmed by Western blotting.
CONCLUSIONS: RCS induces cardioprotection against lethal myocardial ischemia that is at least as powerful as traditional ischemic preconditioning but is mediated through radically different mechanisms.
Authors:
You-Tang Shen; Christophe Depre; Lin Yan; Ji Yeon Park; Bin Tian; Komal Jain; Li Chen; Yan Zhang; Raymond K Kudej; Xin Zhao; Junichi Sadoshima; Dorothy E Vatner; Stephen F Vatner
Related Documents :
17999029 - Redox signaling at reperfusion is required for protection from ischemic preconditioning...
8877789 - No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine.
14634049 - Comparison of three different a1 adenosine receptor antagonists on infarct size and mul...
11560359 - Dilazep dihydrochloride prolongs the infarct size-limiting effect of ischemic precondit...
11294809 - Gene therapy with extracellular superoxide dismutase protects conscious rabbits against...
18477469 - Inhibition of gsk-3 reduces infarct volume and improves neurobehavioral functions.
2115819 - Beneficial effect of intravenous nitroglycerin in patients with non-q myocardial infarc...
17999029 - Redox signaling at reperfusion is required for protection from ischemic preconditioning...
9491959 - Acute myocardial infarction with simultaneous occlusions of two major coronary arteries...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2008-10-20
Journal Detail:
Title:  Circulation     Volume:  118     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2008 Nov 
Date Detail:
Created Date:  2008-11-04     Completed Date:  2008-11-26     Revised Date:  2014-09-24    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1961-9     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Consciousness
Coronary Circulation
Coronary Stenosis / metabolism*,  physiopathology*
Disease Models, Animal
Enzyme Inhibitors / pharmacology
Female
Ischemic Preconditioning, Myocardial*
Myocardial Reperfusion Injury / metabolism*,  physiopathology*
Myocardial Stunning / metabolism,  physiopathology
Nitric Oxide / metabolism
Nitric Oxide Synthase Type II / metabolism
Nitroarginine / pharmacology
Oligonucleotide Array Sequence Analysis
Protein Kinase C-epsilon / metabolism
Recurrence
Swine
Grant Support
ID/Acronym/Agency:
AG014121/AG/NIA NIH HHS; AG023137/AG/NIA NIH HHS; AG023567/AG/NIA NIH HHS; AG027211/AG/NIA NIH HHS; HL033107/HL/NHLBI NIH HHS; HL059139/HL/NHLBI NIH HHS; HL069020/HL/NHLBI NIH HHS; HL069752/HL/NHLBI NIH HHS; P01 AG027211/AG/NIA NIH HHS; P01 AG027211-02/AG/NIA NIH HHS; P01 HL059139/HL/NHLBI NIH HHS; P01 HL059139-10/HL/NHLBI NIH HHS; P01 HL069020/HL/NHLBI NIH HHS; P01 HL069020-08/HL/NHLBI NIH HHS; R01 AG014121/AG/NIA NIH HHS; R01 AG014121-11/AG/NIA NIH HHS; R01 AG023137/AG/NIA NIH HHS; R01 AG023137-05/AG/NIA NIH HHS; R01 AG023567/AG/NIA NIH HHS; R01 AG023567-03/AG/NIA NIH HHS; R01 HL033107/HL/NHLBI NIH HHS; R01 HL033107-24/HL/NHLBI NIH HHS; T32 HL069752/HL/NHLBI NIH HHS; T32 HL069752-05/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 2149-70-4/Nitroarginine; 31C4KY9ESH/Nitric Oxide; EC 1.14.13.39/Nitric Oxide Synthase Type II; EC 2.7.11.13/Protein Kinase C-epsilon
Comments/Corrections
Comment In:
Circulation. 2008 Nov 4;118(19):1915-9   [PMID:  18981312 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking isc...
Next Document:  Basic control of reperfusion effectively protects against reperfusion injury in a realistic rodent m...